1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
  4. > Diagnostics Focus OCTOBER 2016

Diagnostics Focus OCTOBER 2016

  • October 2016
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - Connectivity Will Aid BD's PoC Diagnostic Growth
Industry Brief - Skyline/GLG To Co-Develop Diagnostic Tests For Streamway System
Industry Brief - Transgenomic/Ventana Enter Data Sharing Agreement
Industry Brief - Bruker/3M Expand Licensing Deal For Processing FFPE Tissue Sections
Industry Brief - MDxHealth Gains SelectMDx/ConfirmMDx Distributor in Poland
Industry Brief - Rosetta /Rhenium Ink Distribution Pact For RosettaGX Reveal In Israel
Industry Brief - Transgenomic Signs Deal For ICEme Test Kit Distribution In China/India
Industry Trend Analysis - Liquid Biopsy Market Limited In The Short Term
Industry Brief - MDxHealth Enters Distribution Deal For SelectMDx In Central/South America
Industry Brief - Chembio/Isla Lab Expand Distribution Deal In Caribbean Region
Industry Brief - Novacyt/Cepheid Enter Strategic Alliance For HPV Diagnostics
Industry Brief - Mobidiag Enters Amplidiag Commercialisation Agreement With YouMed
Industry Brief - Almac Diagnostics Partner With ArcherDX
Industry Brief - LBT's APAS Medical Device Granted FDA Approval
Industry Brief - Brainshake Raises Funding For Blood Analysis Service
Industry Brief - Audax Concludes Sale Of Laborie To Patricia
Industry Brief - Eurofins Acquires Megalab
Industry Brief - Pharos Capital Takes Controlling Stake In TechLab
Industry Brief - Theranostix Reports Launch Of P4 Diagnostix
Industry Brief - Venaxis Acquires BiOptix' SPR Technology Platform
Industry Brief - Oxford Immunotec Gains Favourable Decision In Patent Infringement Litigation
Industry Brief - Canon Acquires Minority Stake In T2 Biosystems
Industry Brief - Instrumentation Laboratory Acquires CA Casyso
Industry Brief - Color Genomics Secures Series B Funding
Industry Brief - Chembio Awarded CDC Contract For Zika, Dengue And Chikungunya Surveillance Testing
Industry Brief - iCareDx Changes Name To Acuamark Diagnostics
Industry Brief - Life Length Secures CMS Certification In US
Industry Brief - Oxford Immunotec Secures USD40mn In Debt Funding
Industry Brief - Diagnostics 510(k) Clearances - September 2016
Industry Brief - Trinity Reports Withdrawal Of Troponin Submission
Industry Trend Analysis - Roche Strengthening Liquid Biopsy Position
Industry Trend Analysis - Metabolon Establishing Presence In Metabolomics
Industry Brief - OGT Launches SureSeq myPanel For Detection Of Cancer Gene Variants
Industry Brief - BD MAX CT/GC/TV STIs Assay Granted FDA Clearance
Industry Brief - TAmiRNA Introduces OsteomiR Osteoporosis Detection Test Kit
Industry Brief - ResistancePlus MG Assay Granted CE-IVD Marking
Industry Brief - Chinese FDA Grants Class I Medical Device Status For Sentosa SX101
Industry Brief - Quest Introduces Zika Antibody Test Service
Industry Brief - Agilent Technologies Launches Lung Cancer Panel for Fast FISH Testing
Industry Brief - Roche's Treponema Pallidum Assay Granted FDA Clearance
Industry Brief - Quidel's Solana Influenza A+B Assay Cleared For Sale In US
Industry Brief - Ambry Launches ProstateNext
Industry Brief - FDA Issues EUA For Sentosa Zika Virus Molecular Assay
Industry Brief - ProteaseTag Granted CE Mark Approval
Industry Brief - Serametrix Gains CLIA Certification for MDSC-Based Blood Test
Industry Brief - Roche's Harmony Screening Test Granted CE Mark Approval
Industry Brief - PlasmaSelect 64 Pan-Cancer Tumour Profiling Panel Launched In US
Industry Brief - BD Launches Phoenix M50 ID/AST System To Combat Antimicrobial Resistance
Industry Brief - Diatherix' ABRx Antibiotic Resistance Panel Launched In US
Industry Brief - Castle Biosciences Launches DecisionDx-PRAME
Industry Brief - FDA/CLIA Waives FilmArray Respiratory Panel EZ
Industry Brief - BioPorto Files Pre-Submission Application For The NGAL Test To The FDA
Industry Trend Analysis - TBI Diagnostics Will Gain Increased Investment
Industry Brief - EORTC/Ignyta Expand Collaboration In Precision Medicine
Industry Brief - Diagnostic Conferences - October 2016

Table Of Contents

Diagnostics Focus OCTOBER 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

Tumor Markers: Supplier Shares by Test, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review,  Emerging Opportunities--France, Germany, Italy, Japan, Spain, UK, US

Tumor Markers: Supplier Shares by Test, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review, Emerging Opportunities--France, Germany, Italy, Japan, Spain, UK, US

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

Europe Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

Europe Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

  • $ 12800
  • Industry report
  • August 2016
  • by Venture Planning Group

This unique report provides information not available from any other published source, including volume, sales, and leading supplier shares by test. This comprehensive five-country report identifies and ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.